After rising nearly 25% yesterday on big volume, shares of Cell Therapeutics (CTIC -11%) give back a big chunk today. The stock has been volatile over the past few sessions, largely trading in tandem with big moves in competitor Peregrine Pharmaceuticals (PPHM -11%), who announced favorable news on Mondary of its review of data on its experimental cancer drug bavituximab, saying it wasn't comprimised.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs